Cryoport, Inc. (CYRX)

Market Cap	785.11M
Revenue (ttm)	233.26M
Net Income (ttm)	-107.59M
Shares Out	48.98M
EPS (ttm)	-2.21
PE Ratio	n/a
Forward PE	58.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	383,754
Open	15.85
Previous Close	16.23
Day's Range	15.19 - 16.26
52-Week Range	9.00 - 24.17
Beta	1.59
Analysts	Buy
Price Target	18.25 (+13.85%)
Earnings Date	May 6, 2024

About CYRX

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controll...

• Industry: Integrated Freight & Logistics
• Sector: Industrials
• Founded: 1999
• Employees: 1,019
• Stock Exchange: NASDAQ
• Ticker Symbol: CYRX

Financial Performance

In 2023, Cryoport's revenue was $233.26 million, a decrease of -1.70% compared to the previous year's $237.28 million. Losses were -$107.59 million, 137.3% more than in 2022.

Analyst Forecast

According to 9 analysts, the average rating for CYRX stock is "Buy." The 12-month stock price forecast is $18.25, which is an increase of 13.85% from the latest price.

Price Target

$18.25

(13.85% upside)

Analyst Consensus: Buy